HomeInsightsStock Comparison

Advanced Enzyme Technologies Ltd vs Suven Pharmaceuticals Ltd Stock Comparison

Advanced Enzyme Technologies Ltd vs Suven Pharmaceuticals Ltd Stock Comparison

Last Updated on: Apr 25, 2025

Key Highlights

  • The Latest Trading Price of Advanced Enzyme Technologies Ltd is ₹ 288.6 as of 25 Apr 15:30.
  • The P/E Ratio of Advanced Enzyme Technologies Ltd changed from 12.4 on March 2020 to 29.1 on March 2024 . This represents a CAGR of 18.60% over 5 yearsThe P/E Ratio of Suven Pharmaceuticals Ltd changed from 8.1 on March 2020 to 57.3 on March 2024 . This represents a CAGR of 47.89% over 5 years.
  • The Market Cap of Advanced Enzyme Technologies Ltd changed from ₹ 1598 crore on March 2020 to ₹ 3885 crore on March 2024 . This represents a CAGR of 19.44% over 5 yearsThe Market Cap of Suven Pharmaceuticals Ltd changed from ₹ 2564 crore on March 2020 to ₹ 17223 crore on March 2024 . This represents a CAGR of 46.37% over 5 years.
  • The revenue of Advanced Enzyme Technologies Ltd for the Dec '24 is ₹ 176.8 crore as compare to the Sep '24 revenue of ₹ 155.71 crore. This represent the growth of 13.54% The revenue of Suven Pharmaceuticals Ltd for the Dec '24 is ₹ 322.86 crore as compare to the Sep '24 revenue of ₹ 271.84 crore. This represent the growth of 18.77%.
  • The ebitda of Advanced Enzyme Technologies Ltd for the Dec '24 is ₹ 62.94 crore as compare to the Sep '24 ebitda of ₹ 52.03 crore. This represent the growth of 20.97% The ebitda of Suven Pharmaceuticals Ltd for the Dec '24 is ₹ 133.41 crore as compare to the Sep '24 ebitda of ₹ 118.13 crore. This represent the growth of 12.93%.
  • The net profit of Advanced Enzyme Technologies Ltd changed from ₹ 29.38 crore to ₹ 38.88 crore over 7 quarters. This represents a CAGR of 17.36% The net profit of Suven Pharmaceuticals Ltd changed from ₹ 120.59 crore to ₹ 83.29 crore over 7 quarters. This represents a CAGR of -19.06% .
  • The Dividend Payout of Advanced Enzyme Technologies Ltd changed from 11.56 % on March 2020 to 52.76 % on March 2024 . This represents a CAGR of 35.48% over 5 yearsThe Dividend Payout of Suven Pharmaceuticals Ltd changed from 23.57 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Advanced Enzyme Technologies Ltd

  • Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that has transformed business globally in the manufacturing and sale of enzymes.
  • Advanced Enzyme Technologies Limited was incorporated, as a Private Company on March 15, 1989 as 'Advanced Biochemicals Private Limited' in Maharashtra.
  • The Company thereafter, got converted into a Public Company and the name of the Company changed to Advanced Biochemicals Limited on May 28, 1992.
  • Again, the name was changed to Advanced Enzyme Technologies Limited and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Mumbai on August 19, 2005. In 2011, the company took over Cal-India Foods International, giving the company direct presence in USA. In 2012, the company took over Advanced Supplementary Technologies Corporation for consolidating its presence in USA.

About Suven Pharmaceuticals Ltd

  • Suven Pharmaceuticals Limited (SPL) is a bio-pharmaceutical company, incorporated on 6th November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. The Company is a CDMO that supports global life sciences industry and fine chemical majors in their NCE development endeavors.
  • Its services include custom synthesis, process R&D, scale-up and contract manufacturing of intermediates, APIs and formulations.
  • Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.

Advanced Enzyme Technologies Ltd News Hub

News

Advanced Enzyme Technologies allots 500 equity shares under ESOS

Advanced Enzyme Technologies has allotted 500 equity shares under ESOS on 19 March 2025. C...

Read more

19 Mar 2025 15:59

News

Advanced Enzyme Techs. to announce Quarterly Result

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 8 F...

Read more

03 Feb 2025 10:25

News

Advanced Enzymes announces incorporation of new entity in California for laboratory testing services

The Board of Directors of Advanced Enzymes USA (AEU), a wholly owned subsidiary of Advance...

Read more

05 Dec 2024 12:56

News

Advanced Enzyme Tech drops after PAT slides 5% YoY in Q2 FY25

The revenue de-grew by 3% in Americas, 27% in Europe, 9% in Asia (ex-India) while it grew ...

Read more

11 Nov 2024 13:57

News

Advanced Enzyme Techs. announces board meeting date

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 9 N...

Read more

02 Nov 2024 13:55

News

Advanced Enzyme Techs. to table results

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 9 N...

Read more

31 Oct 2024 13:02

Suven Pharmaceuticals Ltd News Hub

News

Suven Pharmaceuticals to table results

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 M...

Read more

27 Mar 2025 09:42

News

Suven Pharmaceuticals receives credit ratings from CRISIL

Suven Pharmaceuticals announced that CRISIL has assigned/ reaffirmed the following ratings...

Read more

28 Feb 2025 19:46

News

Suven Pharmaceuticals Ltd Surges 5.19%

Suven Pharmaceuticals Ltd gained 5.19% today to trade at Rs 1099.95. The BSE Healthcare in...

Read more

13 Feb 2025 09:30

News

Suven Pharma jumps after Q3 PAT climbs 77% YoY to Rs 83 cr

Revenue from operations jumped 39.7% to Rs 307.15 crore in Q3 FY25 as compared with Rs 219...

Read more

13 Feb 2025 09:55

News

Suven Pharmaceuticals schedules board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 F...

Read more

28 Dec 2024 09:36

News

Suven Pharmaceuticals acquires 56% stake in NJ Bio Inc.

Suven Pharmaceuticals has acquired 56% equity share capital of NJ Bio, Inc. (target compan...

Read more

23 Dec 2024 11:34

SWOT Analysis Of Suven Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Advanced Enzyme Technologies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Suven Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Advanced Enzyme Technologies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Advanced Enzyme Technologies Ltd and Suven Pharmaceuticals Ltd

Which company has a larger market capitalization, Advanced Enzyme Technologies Ltd or Suven Pharmaceuticals Ltd?

Market cap of Advanced Enzyme Technologies Ltd is 3,228 Cr while Market cap of Suven Pharmaceuticals Ltd is 29,103 Cr

What are the key factors driving the stock performance of Advanced Enzyme Technologies Ltd and Suven Pharmaceuticals Ltd?

The stock performance of Advanced Enzyme Technologies Ltd and Suven Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Advanced Enzyme Technologies Ltd and Suven Pharmaceuticals Ltd?

As of April 25, 2025, the Advanced Enzyme Technologies Ltd stock price is INR ₹288.6. On the other hand, Suven Pharmaceuticals Ltd stock price is INR ₹1143.25.

How do dividend payouts of Advanced Enzyme Technologies Ltd and Suven Pharmaceuticals Ltd compare?

To compare the dividend payouts of Advanced Enzyme Technologies Ltd and Suven Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions